PRPO logo.png
Precipio Reminds Investors of Conference Call with Management for Corporate Update and Second Quarter Results
22. August 2018 21:45 ET | Precipio, Inc.
Provides participation details for Thursday, August 23 call NEW HAVEN, Conn., Aug. 22, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), wishes to remind...
PRPO logo.png
Precipio Announces Second Quarter 2018 Financial Results and Provides Corporate Update
17. August 2018 07:37 ET | Precipio, Inc.
Conference call with management to be held Thursday August 23, 2018 at 09:00 Eastern Time NEW HAVEN, Conn., Aug. 17, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc....
PRPO logo.png
Precipio Appoints New Board Member to Replace Departing Director
09. August 2018 07:37 ET | Precipio, Inc.
Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) --...
PRPO logo.png
Precipio Updates Commercial Pipeline for its ICE-COLD PCR™ Liquid Biopsy Technology
19. Juni 2018 07:38 ET | Precipio, Inc.
Trials underway at five laboratories and two diagnostic equipment companies NEW HAVEN, Conn., June 19, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ:PRPO),...
PRPO logo.png
Precipio Launches ICE COLD-PCR™ Liquid Biopsy Kit for Pancreatic Cancer
17. Mai 2018 07:38 ET | Precipio, Inc.
Ultra-sensitive enrichment kit enables development of low cost detection tests, allowing optimized patient treatment NEW HAVEN, Conn., May 17, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
PRPO logo.png
Precipio Announces Participation Details for Upcoming Shareholder Conference Call
26. April 2018 07:38 ET | Precipio, Inc.
NEW HAVEN, Conn., April 26, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), provides details of its previously announced upcoming shareholder conference call...
PRPO logo.png
Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology
03. April 2018 07:38 ET | Precipio, Inc.
NEW HAVEN, Conn., April 03, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today that, in response to recent articles, its approach using ICE...
PRPO logo.png
Precipio Integrates Cost Reducing and Fast Turnaround "High Resolution Melt" into Liquid Biopsy Platform
20. März 2018 07:37 ET | Precipio, Inc.
NEW HAVEN, Conn., March 20, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has successfully incorporated the use of High Resolution Melt...
PRPO logo.png
Precipio Settles Lawsuit with Crede Capital
13. März 2018 08:38 ET | Precipio, Inc.
NEW HAVEN, Conn., March 13, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), announced today it has settled its lawsuit with Crede Capital Group LLC,...
PRPO logo.png
Key Measure of Precipio’s Pathology Sales Growth 4X Prior Quarter
22. Februar 2018 08:39 ET | Precipio, Inc.
NEW HAVEN, Conn., Feb. 22, 2018 (GLOBE NEWSWIRE) -- Precipio, Inc. (NASDAQ:PRPO), announced today that within the first half of Q1-2018 it has set up trials for pathology lab services with 4 times...